title: Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.
authors.affiliation: University of Manchester, Manchester, UK.
authors.forename: S A
authors.initials: SA
authors.lastname: Owen
authors.forename: M
authors.initials: M
authors.lastname: Lunt
authors.forename: S L
authors.initials: SL
authors.lastname: Hider
authors.forename: I N
authors.initials: IN
authors.lastname: Bruce
authors.forename: A
authors.initials: A
authors.lastname: Barton
authors.forename: W
authors.initials: W
authors.lastname: Thomson
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics*; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use*; D010597:Pharmacogenetics; D011237:Predictive Value of Tests; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate